US Stock MarketDetailed Quotes

URGN UroGen Pharma Ltd

Watchlist
  • 12.480
  • -0.220-1.73%
Close Oct 1 16:00 ET
525.58MMarket Cap-4038P/E (TTM)

UroGen Pharma Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

UroGen Pharma Ltd Q2 2024 Earnings Date

Currency：USDAug 13, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
23.96M
21.85M
-2.12M
Miss Est.
+13.36%
+3.35%
-8.83%
EPS
-0.82
-0.91
-0.09
Miss Est.
+19.90%
+11.65%
-10.32%
Analyst Rating
Strong Buy

Sep 30, 2024

UroGen Pharma Ltd Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 29.276M--
--2024/Q3-- / 24.572M--
Aug 13, 20242024/Q221.848M / 23.963M--
May 13, 20242024/Q118.781M / 21.391M--
Mar 14, 20242023/Q423.530M / 22.569M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 29.276M--
--2024/Q3-- / 24.572M--
Aug 13, 20242024/Q221.848M / 23.963M--
May 13, 20242024/Q118.781M / 21.391M--
Mar 14, 20242023/Q423.530M / 22.569M--

Unlock Free Earnings Estimates

UroGen Pharma Ltd Earnings Reports

  • UroGen Pharma Ltd | 10-Q: Q2 2024 Earnings Report

    Aug 13 08:07 ET

  • UroGen Pharma Ltd | 10-Q: Q1 2024 Earnings Report

    May 13 08:09 ET

  • UroGen Pharma Ltd | 10-K/A: Annual report (Amendment)

    Apr 29 08:23 ET

  • UroGen Pharma Ltd | 10-K: FY2023 Annual Report

    Mar 14 08:18 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Sep 30, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data